Henlez

Henlez
Business Name:
Henlez
Category:
Business Description:
Henlez develops a transformative platform therapeutic based on enzyme technology to treat some of the most physically and mentally disabling skin diseases in the world.
Long Business Description:

Henlez was founded by two former Novozymes employees Jeppe Christian Mouritsen and Rikke Nørregaard-Sarup. To realise their idea, they secured a mutually beneficial partnership and technology spin-out deal with Novozymes.
Henlez’s mission is not only to develop a new type of drug, but also on contributing to the public understanding of pathogenesis through collaborations. It is a key focus to Henlez to understand patient perspectives in detail, their problems, practical everyday and longterm challenges – in short working from the get go to map the detailed unmet need. The point is to develop a drug that is on one hand effective and safe, but on the other also affordable and user friendly.

Based in:
Copenhagen
Tags:
Skin disease, enzyme, drug, therapeutics
Total Funding:
Between €100K-€500K
Founded:
2019
Website:
www.henlez.com
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as Henlez? We’re happy to assist you with our Startup Sourcing service.